Related Experiment Video
Updated: Jun 7, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
Apotransferrin protects cortical neurons from hemoglobin toxicity
Jing Chen-Roetling1, Lifen Chen, Raymond F Regan
1Department of Emergency Medicine, Thomas Jefferson University, 1025 Walnut Street, College Building Room 813, Philadelphia, PA 19107, USA.
Apotransferrin, a form of transferrin, may protect neurons from damage caused by hemoglobin after intracerebral hemorrhage. This iron-binding protein shows promise in mitigating iron-mediated neurotoxicity.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Nonheme iron contributes to cell injury following intracerebral hemorrhage.
- High-affinity iron chelators can be toxic due to metal sequestration.
- Transferrin uniquely chelates iron and delivers it via receptor-mediated endocytosis.
Purpose of the Study:
- To evaluate the efficacy of transferrin against iron-mediated neuronal injury.
- To assess transferrin's effect on hemoglobin neurotoxicity in a cell culture model.
Main Methods:
- Used a cell culture model of hemoglobin neurotoxicity.
- Measured neuronal death via lactate dehydrogenase release.
- Assessed iron, malondialdehyde, protein carbonyls, ferritin, and heme oxygenase-1 levels.
- Investigated transferrin receptor-1 expression.
Main Results:
- Hemoglobin exposure caused significant neuronal death and increased markers of oxidative stress and iron.
- Apotransferrin, but not holotransferrin, attenuated hemoglobin-induced neurotoxicity and associated markers.
- Apotransferrin's protective effect was comparable to deferoxamine and not affected by holotransferrin.
Conclusions:
- Apotransferrin may mitigate neurotoxicity associated with hemoglobin after intracerebral hemorrhage.
- Increasing apotransferrin concentration in perihematomal tissue could be therapeutically beneficial.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
Hepatic Encephalopathy
The Blood-brain Barrier
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Transcellular Transport of Solutes
